ABOUT US

Inspiring New Approaches

At Halozyme, we are focused on innovative and disruptive solutions that provide new therapeutic options that could significantly improve the patient experience. We also support our partners with our drug delivery technologies that could significantly streamline treatment protocols for emerging and established therapies, with the potential to offer patients the valuable benefit of convenience and time.

The patient experience is at the center of everything we do.

Our Focus

Technology Platforms

Our commercially validated ENHANZE® drug delivery technology, based on our proprietary enzyme rHuPH20, is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids. When co-formulated with other drugs, ENHANZE® has the potential to reduce treatment burden for patients, including potentially reducing treatment administration from hours-long IV infusions to subcutaneous injections delivered in minutes.

We have expanded our technology platform offering by adding a range of auto-injectors designed for subcutaneous and intramuscular use. With more than 30 years of experience in auto-injector device development and engineering, our internal development team specializes in creating custom designed drug delivery devices that address patient and therapeutic needs.

Commercial Products

In addition, we market and commercialize four FDA-approved products featuring our unique and proprietary development and delivery technologies.

Values

Our values unite us at Halozyme. As we relentlessly work toward our mission of improving patient experiences and outcomes, these values represent the core of each and every one of our team members.

We Respect and Value the Team

  • We work together and help each other achieve common goals.
  • We reward significant contributions and hire, develop and recognize talent that share our values.
  • We value each other’s opinion and disagree with each other respectfully.
  • We are committed to openness, respect and trust in our relationships.

We Focus on Patients

  • We are committed to providing patients with safe and effective therapies.
  • We work with our partners to help design products that optimize the patient experience.
  • We positively impact the lives of patients and their families.

We Do the Right Thing

  • We act with integrity and honesty to uphold the highest ethical standards.
  • We take pride in the quality of our work and our relationships.
  • We contribute to society and human welfare through the responsible development of our products.

We Are All Empowered and Accountable

  • We make fact-based, informed decisions and are enabled to set, prioritize and meet goals.
  • We are flexible and work together to overcome unforeseen events.
  • We fulfill our commitments to patients, partners, shareholders and each other.

We Innovate

  • We address gaps and weaknesses with unique and efficient solutions.
  • We improve processes and reduce costs without sacrificing quality.

Leadership Team

Helen Torley, M.B. Ch. B., M.R.C.P.

President and Chief Executive Officer

Mark Snyder

Chief Legal Officer

Nicole LaBrosse

Chief Financial Officer

Michael J. LaBarre, Ph.D.

Chief Technical Officer

Steve Knowles, MB.BS, M.R.C.P., M.F.P.M.

Chief Medical Officer
Chris Wahl

Chris Wahl, MD, MBA

Chief Business Officer

Gary Grote

Chief Commercial Officer

Christopher Bryant, Ph.D.

Chief Manufacturing Officer and Head of Technical Operations

Kristin Schwartzbauer

Head of Quality

Tram Bui

Head of Investor Relations and Corporate Communications

Amy Fox

Chief Human Resources Officer

Board of Directors

Jeffrey W. Henderson

Chair of the Board

Jean-Pierre Bizzari, M.D.

Bernadette Connaughton

James M. Daly

Barbara Duncan

Connie L. Matsui

Moni Miyashita

Matthew L. Posard

Helen Torley, M.B. Ch. B., M.R.C.P.

President and Chief Executive Officer

Copyright© 2015-2023. Halozyme, Inc. All rights reserved. All trademarks belong to their respective owners.